Transcripts Celyad Oncology SA

Actions

Marché Fermé - Euronext Bruxelles 17:55:00 26/08/2026			Varia. 5j.	Varia. 1 janv.
0,2610 ^EUR	+1,56 %		-4,40 %	+53,53 %

14/07	Celyad Oncology va lever des fonds via un placement privé	MT
15/04	Prelude Therapeutics Incorporated nomme Charles Morris au poste de Chief Medical Officer, avec effet au 20 avril 2026	CI

05/09/23	Transcript : Celyad Oncology SA, H1 2023 Earnings Call, Sep 05, 2023
24/03/23	Transcript : Celyad Oncology SA, 2022 Earnings Call, Mar 24, 2023
05/08/22	Transcript : Celyad Oncology SA, H1 2022 Earnings Call, Aug 05, 2022
25/03/22	Transcript : Celyad Oncology SA, 2021 Earnings Call, Mar 25, 2022
13/12/21	Transcript : Celyad Oncology SA - Special Call
05/08/21	Transcript : Celyad Oncology SA, H1 2021 Earnings Call, Aug 05, 2021
20/07/21	Transcript : Celyad Oncology SA - Special Call
11/06/21	Transcript : Celyad Oncology SA - Special Call
25/03/21	Transcript : Celyad Oncology SA, 2020 Earnings Call, Mar 25, 2021
09/03/21	Transcript : Celyad Oncology SA Presents at H.C. Wainwright Virtual Global Life Sciences Conference, Mar-09-2021 07:00 AM
07/12/20	Transcript : Celyad Oncology SA - Special Call
29/09/20	Transcript : Celyad Oncology SA - Special Call
07/08/20	Transcript : Celyad Oncology SA, H1 2020 Earnings Call, Aug 07, 2020
01/06/20	Transcript : Celyad SA - Special Call
25/03/20	Transcript : Celyad SA, 2019 Earnings Call, Mar 25, 2020